Navigation Links
Cepheid Reports Fourth Quarter And Full Year 2012 Results
Date:1/24/2013

HBDC program," said John Bishop, Cepheid's Chief Executive Officer.  "Despite these distractions, we were able to grow our clinical test revenue by 32%, including 25% growth in our commercial business."

Continued Bishop, "We are proud of our commitment to innovation, and our investment in R&D continues to be among the most aggressive in the industry.  As we move into 2013 and beyond, Cepheid is entering a pivotal period of Xpert test menu expansion with a number of high volume, high value tests that substantially extend our opportunities in new and existing markets.  We fully expect this product cycle to drive both market expansion and menu consolidation within accounts thereby benefiting continued, industry-leading revenue growth and improving profitability."

Operational Overview

  • Fourth quarter of 2012 Clinical sales of $82.2 million grew 19% from $68.9 million in the fourth quarter of 2011, and total fourth quarter of 2012 product sales of $89.7 million grew 17% from the same quarter a year ago.  For the year ended December 31, 2012, total Clinical sales of $286.3 million grew 21% from $236.0 million reported for 2011. 
  • By industry, product sales were, in millions:
  • Three Months Ended December 31,Full Year Ended December 31,20122011Change20122011ChangeClinical Systems

    $  13.4$  19.9-33%$
    52.8$
    58.6-10%Clinical Reagents

    68.849.040%233.5177.432%Total Clinical 82.268.919%286.3236.021%Non-Clinical

    7.58.0-6%35.229.519%Total Product Sales$  89.7$  76.917%$  321.5$  265.521%


  • By geography, product sales were, in millions:
  • Three Months Ended December 31,Full Year Ended December 31,20122011Change20122011ChangeNorth AmericaClinical

    $  54.4$  46.417%$  190.0$  167.913%Other

    6.07.2-17%29.025.016%Total North America60.453.613%219.0192.914%InternationalClinical

    27.822.524%96.368.
    '/>"/>

    SOURCE Cepheid
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12

    Related medicine technology :

    1. Cepheid to Webcast Upcoming Financial Presentations
    2. Cepheid Announces Executive Vice President Emerging Markets
    3. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
    4. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
    5. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
    6. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
    7. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
    8. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
    9. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
    10. Luminex Corporation Reports First Quarter 2012 Results
    11. Hospira Reports First-Quarter 2012 Results
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/23/2015)...  The Partnership to Fight Chronic Disease (PFCD) released a public opinion ... a new study analyzing the impact of increased cost sharing on ... working to educate policy makers and the public on the costs ... on how the Iowa healthcare exchange could ...
    (Date:1/23/2015)... , Jan. 23, 2015  Northwest Biotherapeutics, Inc. (NASDAQ: ... immune therapies for operable and inoperable solid tumor cancers, announced ... the 7 th Annual Phacilitate Immunotherapy Forum in ... at Phacilitate will take place on January 26 at 10:30 ...
    (Date:1/23/2015)... More than a third of reproductive-aged women enrolled in Medicaid, ... filled a prescription for an opioid pain medication each year ... and Mortality Weekly Report (MMWR). Opioids are ... severe pain.  They are also found in some prescription cough ...
    Breaking Medicine Technology:New research shows Iowa health exchange would benefit from improvements 2New research shows Iowa health exchange would benefit from improvements 3NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3
    ... MOUNTAIN VIEW, Calif., March 7, 2011 IRIDEX Corporation (Nasdaq: ... to make an investor presentation at the ROTH 23rd Annual ... pm Pacific Time.  The conference is being held March 13-16 ... The presentation will be accessible by live webcast ...
    ... Grifols, a global healthcare company and biopharmaceutical manufacturer ... established an Expert Advisory Council in Transfusion Medicine drawing ... from across the globe.  The role of the Expert ... to Grifols, own transfusion medicine research and development activities. ...
    Cached Medicine Technology:Grifols Establishes Expert Advisory Council in Transfusion Medicine 2Grifols Establishes Expert Advisory Council in Transfusion Medicine 3
    (Date:1/22/2015)... 20 years, Dr. David Cruz of Cruz Chiropractic Care ... about every type of injury that can result from car accidents ... years, the team at Doctors on Liens has been ... With the combined breadth of experience between the two, ...
    (Date:1/22/2015)... Joan Lunden, award-winning American journalist, beloved television ... 32nd Annual Miami Breast Cancer Conference planned ... (PER®) , shares that “a fast-growing, virulent” cancer in ... had not followed up her clean mammogram with an ...
    (Date:1/22/2015)... Calif. (PRWEB) January 22, 2015 ... Susan Bonilla (D-Concord) and Kristin Olsen (R-Modesto) were ... their leadership in advancing biotechnology, biomedical science, medical ... and Olsen each received the “2014 Life Sciences ...
    (Date:1/22/2015)... IsoComforter, Inc. has introduced the most innovative and ... to treat specific body parts and muscle groups. , ... to use patented cold therapy machine with the innovative IsoTube ... muscle injuries. IsoComforter has become the industry leader in ...
    (Date:1/22/2015)... January 22, 2015 Payday lending practices ... communities and cause financial distress to the states that ... at Howard University’s Center on Race and Wealth. , ... economic activity, payday loans at the same time substantially ...
    Breaking Medicine News(10 mins):Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2
    ... D.C. Areas of the brain responsible for ... patients who exercised following a medication holiday, say ... say the changes indicate brain functioning is more ... the brains resources is devoted to processing bothersome ...
    ... SUNDAY, Nov. 13 (HealthDay News) -- When added to standard ... people with "acute coronary syndrome" lower their risk of death, ... Acute coronary syndrome is an umbrella term that includes people ... finding "opens up a new area for treating this very ...
    ... study has identified a novel gene mutation that appears ... cases of malignant melanoma, the most deadly form of ... gene encoding MITF, a transcription factor that induces the ... in which melanoma originates. While previous research has ...
    ... A wearable defibrillator can prevent sudden death in people ... the American Heart Association,s Scientific Sessions 2011. , Wearable ... at higher risk for sudden cardiac arrest, including those ... a condition that prevents or delays them from receiving ...
    ... women with breast cancer have taken the drug tamoxifen, only ... tumors do not respond to the treatment at all, or ... at the University of California, San Francisco (UCSF) have discovered ... way to defeat it. On Sunday, Nov. 13, ...
    ... (HealthDay News) -- All U.S. children between the ages of ... to new guidelines endorsed by the nation,s leading group of ... guidelines that suggest such testing be done only for children ... blood cholesterol, which is one of the major risk factors ...
    Cached Medicine News:Health News:Improved memory efficiency seen after aerobic exercise in fibromyalgia patients 2Health News:Blood Thinner Xarelto Shows Promise for Heart Patients 2Health News:Blood Thinner Xarelto Shows Promise for Heart Patients 3Health News:Blood Thinner Xarelto Shows Promise for Heart Patients 4Health News:Newly identified gene mutation adds to melanoma risk 2Health News:Newly identified gene mutation adds to melanoma risk 3Health News:Wearable defibrillator can prevent death in people with arrhythmias 2Health News:Tamoxifen resistance -- and how to defeat it 2Health News:Tamoxifen resistance -- and how to defeat it 3Health News:Tamoxifen resistance -- and how to defeat it 4Health News:New Guidelines Urge Cholesterol Check for All Kids Ages 9 to 11 2Health News:New Guidelines Urge Cholesterol Check for All Kids Ages 9 to 11 3Health News:New Guidelines Urge Cholesterol Check for All Kids Ages 9 to 11 4
    200 L, Bulk, yellow Recommended for 20, 25, 50, 100 and 200 L pipettes. Can also be used with 300 L pipettes when pipetting 200 L or less....
    For restriction digests, immuno-precipitations, enzyme assays, TLC spotting and others...
    The Finntip 20 is suitable for applications requiring high precision and volumes of 0.2-20 ul. The tips are provided in convenient racks of 384 tips....
    10 L, Bulk Recommended for 2, 5, 10 L pipettes....
    Medicine Products: